Dawnrays Pharmaceutical Holdings Ltd. (HK:2348) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Dawnrays Pharmaceutical (Holdings) Ltd. has announced the resignation of its CEO, Mr. Wu Weixian, effective from 5:00 pm on 11 September 2024, due to his desire to focus on personal commitments. The company is actively seeking a replacement and will update shareholders and the Hong Kong Stock Exchange once a suitable candidate is found. The board extends its gratitude to Mr. Wu for his services during his tenure.
For further insights into HK:2348 stock, check out TipRanks’ Stock Analysis page.